Skip to main content
Top
Published in: International Urology and Nephrology 3/2010

01-09-2010 | Urology - Original Paper

Bladder cancer incidence and mortality rates compared to ecologic factors among states in America

Authors: Janet L. Colli, Peter N. Kolettis

Published in: International Urology and Nephrology | Issue 3/2010

Login to get access

Abstract

Purpose

Smoking, inadequate vitamin D and pesticide exposure have been linked to bladder cancer (BCa) in past studies. The objective of this study is to explore associations between BCa rates and these risk factors.

Materials and methods

BCa incidence and mortality rates among states were compared to smoking; solar ultraviolet (UV) radiation levels and drinking water from a surface water supply (which has greater residual pesticide contamination than groundwater and both are used as sources for drinking water). Lack of health insurance, median family income and urbanization were included to adjust for access to health care and socioeconomic status.

Results

BCa incidence and mortality correlated directly with smoking and inversely with solar UV radiation for males and females. BCa mortality correlated directly with drinking surface water for both sexes. Lack of health insurance correlated inversely with BCa incidence for females and trended toward significance for males. Multivariable analyses identified solar UV radiation as the best predictor of BCa incidence in males and solar UV radiation and smoking in females. Solar UV radiation, smoking and drinking surface water were the best predictors of BCa mortality in males, while smoking and drinking surface water were the best predictors of mortality in females.

Conclusions

BCa incidence and mortality for both sexes correlated directly with smoking and inversely with solar UV radiation levels. BCa mortality for both sexes correlated with drinking water from a surface water source. It is hypothesized that BCa mortality risks may increase from drinking water contaminated with low levels of pesticides.
Literature
1.
go back to reference Hemelt M, Yamamoto H, Cheng KK, Zeegers MP (2008) The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer 2:412–419 Hemelt M, Yamamoto H, Cheng KK, Zeegers MP (2008) The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer 2:412–419
2.
go back to reference Janković S, Radosavljević V (2007) Risk factors for bladder cancer. Tumori 1:4–12 Janković S, Radosavljević V (2007) Risk factors for bladder cancer. Tumori 1:4–12
3.
go back to reference Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16:83–95CrossRefPubMed Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16:83–95CrossRefPubMed
4.
go back to reference Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 7:451–459 Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 7:451–459
5.
go back to reference Tuohimaa P, Pukkala E, Scélo G et al (2007) Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 11:1701–1712CrossRef Tuohimaa P, Pukkala E, Scélo G et al (2007) Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 11:1701–1712CrossRef
6.
go back to reference Grant WB (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 6:1867–1875CrossRef Grant WB (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 6:1867–1875CrossRef
7.
go back to reference Grant WB (2003) Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 164:371–377PubMed Grant WB (2003) Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 164:371–377PubMed
8.
go back to reference Boscoe FP, Schymura MJ (2006) Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer 6:264CrossRefPubMed Boscoe FP, Schymura MJ (2006) Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer 6:264CrossRefPubMed
9.
go back to reference Grant WB, Garland CF (2006) The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26(4A):2687–2699PubMed Grant WB, Garland CF (2006) The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26(4A):2687–2699PubMed
10.
go back to reference Hayes RB, Friedell GH, Zahm SH et al (1993) Are the known bladder cancer risk-factors associated with more advanced bladder cancer? Cancer Causes Control 2:157–162CrossRef Hayes RB, Friedell GH, Zahm SH et al (1993) Are the known bladder cancer risk-factors associated with more advanced bladder cancer? Cancer Causes Control 2:157–162CrossRef
11.
go back to reference Viel JF, Challier B (1995) Bladder cancer among French farmers: does exposure to pesticides in vineyards play a part? Occup Environ Med 9:587–592CrossRef Viel JF, Challier B (1995) Bladder cancer among French farmers: does exposure to pesticides in vineyards play a part? Occup Environ Med 9:587–592CrossRef
12.
go back to reference Peláez S, Hierro I, Oña S et al (2004) Relationship between pesticide exposure and low-grade superficial bladder urothelial carcinoma [Article in Spanish]. Med Clin (Barc) 123(15):571–574CrossRef Peláez S, Hierro I, Oña S et al (2004) Relationship between pesticide exposure and low-grade superficial bladder urothelial carcinoma [Article in Spanish]. Med Clin (Barc) 123(15):571–574CrossRef
13.
go back to reference Zarzour AH, Selim M, Abd-Elsayed AA et al (2008) Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics. BMC Cancer 8:250CrossRefPubMed Zarzour AH, Selim M, Abd-Elsayed AA et al (2008) Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics. BMC Cancer 8:250CrossRefPubMed
14.
go back to reference Koutros S, Lynch CF, Ma X et al (2009) Heterocyclic aromatic amine pesticide use and human cancer risk: results from the U.S. Agricultural Health Study. Int J Cancer 124(5):1206–1212CrossRefPubMed Koutros S, Lynch CF, Ma X et al (2009) Heterocyclic aromatic amine pesticide use and human cancer risk: results from the U.S. Agricultural Health Study. Int J Cancer 124(5):1206–1212CrossRefPubMed
15.
go back to reference Pesticides in the Nation’s Streams and Ground Water, 1992–2001 (2006) Fact Sheet 2006–3028, U.S. Geological Survey Pesticides in the Nation’s Streams and Ground Water, 1992–2001 (2006) Fact Sheet 2006–3028, U.S. Geological Survey
16.
go back to reference Hutson SS, Barber NL, Kenny JF et al (2004) Estimated use of water in the United States in 2000. U.S. Geological Survey Circular 1268, U.S. Department of the Interior U.S. Geological Survey, Reston, VA, USA Hutson SS, Barber NL, Kenny JF et al (2004) Estimated use of water in the United States in 2000. U.S. Geological Survey Circular 1268, U.S. Department of the Interior U.S. Geological Survey, Reston, VA, USA
17.
go back to reference Nieder AM, MacKinnon JA, Fleming LE et al (2009) Bladder cancer clusters in Florida: identifying populations at risk. J Urol 1:46–50CrossRef Nieder AM, MacKinnon JA, Fleming LE et al (2009) Bladder cancer clusters in Florida: identifying populations at risk. J Urol 1:46–50CrossRef
18.
go back to reference Cantor KP, Hoover R, Hartge P et al (1987) Bladder cancer, drinking water source, and tap water consumption: a case–control study. J Natl Cancer Inst 6:1269–1279 Cantor KP, Hoover R, Hartge P et al (1987) Bladder cancer, drinking water source, and tap water consumption: a case–control study. J Natl Cancer Inst 6:1269–1279
19.
go back to reference King WD, Marrett LD (1996) Case–control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control 6:596–604CrossRef King WD, Marrett LD (1996) Case–control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control 6:596–604CrossRef
20.
go back to reference Bove GE Jr, Rogerson PA, Vena JE (2007) Case–control study of the effects of trihalomethanes on urinary bladder cancer risk. Arch Environ Occup Health 1:39–47CrossRef Bove GE Jr, Rogerson PA, Vena JE (2007) Case–control study of the effects of trihalomethanes on urinary bladder cancer risk. Arch Environ Occup Health 1:39–47CrossRef
21.
go back to reference Serretta V, Altieri V, Morgia G et al (2009) Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma. Urol Int 3:318–323CrossRef Serretta V, Altieri V, Morgia G et al (2009) Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma. Urol Int 3:318–323CrossRef
22.
go back to reference Welch AH, Westjohn DB, Helsel DR et al (2000) Arsenic in ground water of the United States—occurrence and geochemistry. Ground Water 38(4):589–604CrossRef Welch AH, Westjohn DB, Helsel DR et al (2000) Arsenic in ground water of the United States—occurrence and geochemistry. Ground Water 38(4):589–604CrossRef
23.
go back to reference CDC’s National Program of Cancer Registries Cancer Surveillance System (NPCR-CSS). January 2005 data submission and SEER November 2004 submission as published in United States Cancer Statistics 2002 CDC’s National Program of Cancer Registries Cancer Surveillance System (NPCR-CSS). January 2005 data submission and SEER November 2004 submission as published in United States Cancer Statistics 2002
24.
go back to reference Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: mortality—All COD, Public-Use With State, Total U.S. (1969–2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006. Underlying mortality data provided by NCHS (www.cdc.gov/nchs) Surveillance, Epidemiology, and End Results (SEER) Program (www.​seer.​cancer.​gov) SEER*Stat Database: mortality—All COD, Public-Use With State, Total U.S. (1969–2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006. Underlying mortality data provided by NCHS (www.​cdc.​gov/​nchs)
27.
go back to reference US Cancer Statistics Working Group (2007) United States cancer statistics: 2004 incidence and mortality. US Department of Health and Human Services, CDC, National Cancer Institute, Atlanta, GA US Cancer Statistics Working Group (2007) United States cancer statistics: 2004 incidence and mortality. US Department of Health and Human Services, CDC, National Cancer Institute, Atlanta, GA
28.
go back to reference Status of Pesticides in Registration, Reregistration and Special Review. Special Review and Reregistration Division, Office of Pesticide Programs, U.S. Environmental Protection Agency, Washington, DC. Spring 1998 Status of Pesticides in Registration, Reregistration and Special Review. Special Review and Reregistration Division, Office of Pesticide Programs, U.S. Environmental Protection Agency, Washington, DC. Spring 1998
29.
go back to reference Rusiecki JA, Hou L, Lee WJ, Blair A et al (2006) Cancer incidence among pesticide applicators exposed to metolachlor in the Agricultural Health Study. Int J Cancer 12:3118–3123CrossRef Rusiecki JA, Hou L, Lee WJ, Blair A et al (2006) Cancer incidence among pesticide applicators exposed to metolachlor in the Agricultural Health Study. Int J Cancer 12:3118–3123CrossRef
30.
go back to reference Glickman LT, Schofer FS, McKee LJ et al (1989) Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs. J Toxicol Environ Health 28(4):407–414CrossRefPubMed Glickman LT, Schofer FS, McKee LJ et al (1989) Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs. J Toxicol Environ Health 28(4):407–414CrossRefPubMed
31.
go back to reference Glickman LT, Raghavan M, Knapp DW et al (2004) Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc 8:1290–1297CrossRef Glickman LT, Raghavan M, Knapp DW et al (2004) Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc 8:1290–1297CrossRef
Metadata
Title
Bladder cancer incidence and mortality rates compared to ecologic factors among states in America
Authors
Janet L. Colli
Peter N. Kolettis
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9655-5

Other articles of this Issue 3/2010

International Urology and Nephrology 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.